Margaret Salisbury is a Respiratory physician. OpenAlex indexes 95 publications with 3,705 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 37232
Telephone
615-322-3000Provider last certified this registry record 7 Mar 2024.
Clinical trials
- Mechanisms of Familial Pulmonary Fibrosis
Sponsor: Vanderbilt University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20248 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
61%Kinase inhibitor42.6%Ofev100%Part D≥17 patientsPyridone18.4%Pirfenidone100%Part D<11 patientsRespiratory
35.1%Corticosteroid20.3%Fluticasone Propionate55%Breztri Aerosphere26%Trelegy Ellipta19%Part D<11 patientsbeta2-Adrenergic Agonist7.5%Albuterol Sulfate Hfa100%Part D≥11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.9%Proton pump inhibitor3.9%Nexium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Reconceptualizing Disease Progression in Pulmonary Fibrosis
Vanderbilt University Medical Center
FY2026$739,660R01HL179065 - Reconceptualizing Disease Progression in Pulmonary Fibrosis
Vanderbilt University Medical Center
FY2025$797,845R01HL179065 - Defining the biologic and physiologic trajectory of presymptomatic through advanced pulmonary fibrosis
Vanderbilt University Medical Center
FY2023$768,003R56HL166941
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Identification of a conserved sequence of disease progression in Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine
2026 - Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement
American Journal of Respiratory and Critical Care Medicine
2025 - Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”